Tag Archives: Cardiovascular

Hemostats Market: Growth in the Number of Hospitals and Surgical Centers

The increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries are driving the growth of hemostats market.

In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market. On the other hand, high cost of hemostats and dearth of skilled professionals are expected to hinder the growth of this market.

Hemostats Market worth $3.03 Billion by 2023 – Application (Gynecology, Neurology, Cardiovascular, Reconstructive)

The increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries driving the growth Hemostats Market. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period.

How much is the Hemostats Market worth?

Worldwide Hemostats Market Analysis and Forecast Report Till 2023

The report Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) – ****** Forecast to 2023″, The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.

Don’t miss out on business opportunities in Hemostats Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=9571619

“The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018.”

Worldwide Fluoroscopy Equipment Market Analysis and Forecast Report Till 2024

The report Fluoroscopy Equipment Market by Product (Fixed C-arms, Fluoroscopy Systems (Remote Controlled), Mobile C-arms), and Application (Diagnostic (Cardiology, Gastroenterology), Surgical (Orthopedic, Cardiovascular) – Analysis & ****** Forecast to 2024″, The ****** fluoroscopy equipment market is projected to reach USD 7.1 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 4.4%.

Don’t miss out on business opportunities in Fluoroscopy Equipment Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=23056341

 “The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.”

Fluoroscopy Equipment Market to Reflect Impressive Growth in Healthcare Industry

The major factors driving the growth of the fluoroscopy equipment are the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.

What the Market Looks Like?

Predicted to grow at a CAGR of 4.4% during the forecast period, the ****** Fluoroscopy Equipment market is estimated to reach USD 7.1 billion by the end of 2024.

“The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.”

Emerging Trends Hemostats Market by Types, Revenue, Industry Growth and Forecast 2023

Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.

The Hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.14 billion in 2017 at a CAGR of 6.0%.

+ Market Dynamics 

+ Drivers

+ Increasing Number of Surgical Procedures
+ Growing Number of Regulatory Approvals
+ Increasing Incidence of Sports-Related Injuries and Spinal Ailments
+ Rising Focus on Effective Blood Loss Management in Patients During Surgeries

Emerging Trends Fluoroscopy Equipment Market by Types, Revenue, Industry Growth and Forecast 2024

Growth in the fluoroscopy equipment market is attributed to factors such as advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, and the growing prevalence of chronic diseases.

The Fluoroscopy Equipment market is expected to grow from USD 5.7 billion in 2019 to USD 7.1 billion by 2024, at a CAGR of 4.4% during the forecast period.

+ Market Dynamics 

+ Drivers

+ Advantages of FPDs Over Image Intensifiers
+ Use of Fluoroscopy in Pain Management
+ Reimbursement Cuts for Analog Radiography Systems
+ Rising Geriatric Population and Growing Chronic Disease Prevalence
+ Awareness Programs, Conferences, and Funding Activities

Vascular Closure Devices Market Indicates Impressive Growth Rate in Healthcare Industry

The ****** vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. 

The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market

Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.

How Biomaterials is Revolutionizing the ****** Healthcare Industry?

Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms in the US are expected to restrain the growth.